Narnatumab

Narnatumab is a human monoclonal antibody designed for the treatment of cancer.^[1] Clinical development was abandoned after phase I trials.^[2][3]

Narnatumab

Monoclonal antibody
Type	Whole antibody
Source	Mouse
Target	MST1R (aka RON)
Clinical data
ATC code	none
Identifiers
CAS Number	1188275-92-4 N
ChemSpider	none
UNII	R42YK40U9M
KEGG	D10074
Chemical and physical data
Formula	C6454H10026N1754O2020S44
Molar mass	145922.10 g·mol−1
NY (what is this?)  (verify)

Narnatumab was developed by ImClone Systems.